Today: 27 June 2026
Almonty stock price jumps as analyst target hikes put tungsten squeeze back in play
3 February 2026
1 min read

Almonty stock price jumps as analyst target hikes put tungsten squeeze back in play

New York, Feb 3, 2026, 13:20 ET — Regular session

  • Almonty shares jump roughly 13% in midday trading, boosted by heavy volume
  • Alliance Global Partners raises its price target to $14 while maintaining a buy rating
  • Attention turns to tungsten pricing cues and the upcoming earnings release date

Almonty Industries Inc shares jumped roughly 13.4% to $12.87 during midday trading on Nasdaq Tuesday. The surge came after Jake Sekelsky bumped his price target for the tungsten miner up to $14 from $9.50. The stock fluctuated between $11.52 and $13.07, with over 4.2 million shares trading hands.

A separate note from Sphene Capital GmbH highlighted tungsten prices breaking past $1,000 per MTU — the metric ton unit used in trading — for APT, ammonium paratungstate, a key intermediate often serving as a benchmark. Sphene set its reference price near $1,250 per MTU and raised its 36-month price target to C$20.10, up from C$13.50.

This is significant since tungsten now falls under the same policy category as other “critical minerals” — a niche market with defence and industrial applications that governments prefer to source beyond China. When prices tighten, stocks, particularly smaller ones, can see outsized moves.

The Wall Street Journal reported on Feb. 1, with the story republished by the company, that miners are enlisting retired U.S. generals to better navigate Washington and win Department of Defense contracts. Almonty brought on retired four-star Army Gen. Gustave Perna and appointed retired Brig. Gen. Steven Allen to an operating role. Perna’s advice was blunt: “Why are you knocking on that door? You should be over here.” Chris Berry of House Mountain Partners told the Journal that these military hires indicate “a level of access in the Pentagon.” The article also highlighted MP Materials, United States Antimony, and USA Rare Earth as similar cases. Almonty Industries

Sekelsky linked the target increase to strategic initiatives and strong tungsten prices. He also pointed to Almonty’s equity financing and the launch of active mining at South Korea’s Sangdong Mine as key drivers behind “significant growth” expected in 2026.

A price target reflects an analyst’s projection of where a stock might trade down the line—not a guarantee. Yet traders keep a close eye on them, since these estimates can lure in new buyers and push short sellers to cover, especially when a stock has low float.

The story hinges heavily on two fast-moving factors: commodity prices and execution. If tungsten prices drop, or mine ramp-ups drag out longer than planned, today’s bid could vanish just as quickly.

Investors will be watching closely for any updates on ramp timing, contracts, and cash needs. The stock has shown sensitivity to research notes and macro headlines, a trend that can swing in either direction.

Traders are eyeing Almonty’s fourth-quarter results, set for release on March 26, according to MarketWatch.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • AI Stocks with Real Revenue and Early Stage Risks: BrainChip Holdings and Xero Reviewed
    June 27, 2026, 2:09 PM EDT. Artificial intelligence (AI) influences sectors from chips to cloud platforms, drawing investor focus on companies central to AI advancements. Australian firm BrainChip Holdings (ASX:BRN) develops neuromorphic AI processors with revenues around US$1.9 million, primarily from North America, but faces funding risks and operates at a loss. Its technology targets low-power, real-time edge computing for defense and industrial sectors. New Zealand-based Xero (ASX:XRO) delivers cloud accounting and payroll software, generating about NZ$2.75 billion in revenue with AI-enhanced reporting tools. While BrainChip presents a high risk-reward scenario due to early-stage status and financial uncertainties, Xero offers a more mature revenue base amid ongoing AI integration into small business software. Investors should weigh BrainChip's growth potential against its financial risks and consider Xero's steady market position.

Latest articles

Verizon (NYSE:VZ) spectrum outlay grabs focus after Dow drop

Verizon (NYSE:VZ) spectrum outlay grabs focus after Dow drop

27 June 2026
Verizon surged 2.6% last week to $46.54 as investors digested its $3.16 billion spend on 82 AWS-3 spectrum licenses—about 1.6% of its market value and equal to a quarter’s dividend payout—while heavy trading followed news that Alphabet will replace Verizon in the Dow before Monday’s open.
IRS tax preparer fraud case draws investor attention to 75 million paid returns

IRS tax preparer fraud case draws investor attention to 75 million paid returns

27 June 2026
The Supreme Court let stand a ruling allowing the IRS unlimited time to assess taxes on returns tainted by preparer fraud, even if the taxpayer was unaware, spotlighting risk for 75 million paid-preparer e-filed returns and raising the stakes for firms like H&R Block and Intuit as investors watch the growing share and complexity of assisted tax filings.
Xero share price jumps on AI push and fresh US payments numbers — here’s what investors watch next
Previous Story

Xero share price jumps on AI push and fresh US payments numbers — here’s what investors watch next

Bitcoin price today: BTC slides below $76,000 as liquidations and Fed bets jolt crypto
Next Story

Bitcoin price today: BTC slides below $76,000 as liquidations and Fed bets jolt crypto

Go toTop